An oral tablet formulation of Livmarli (maralixibat) is now approved in Canada to treat pruritus (itching) caused by Alagille syndrome. An oral solution…

Dosing has begun in a Phase 1/2 clinical trial testing CRMA-1001, Nchroma Bio’s experimental epigenetic therapy being studied as a potential functional cure for…

Receiving a liver transplant from a living donor is associated with an increased risk — as much as four times higher — of disease recurrence…